CompoAtlas

Glucosamine (1000 mg)

Natural health product licensed in Canada

Other names
Pharmavigor
Licence holder
Pharmavigor
NPN or DIN-HM
80002033
Status
Active licence
Licence date
22 August 2006
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de chondroïtine500 mgNot calculated

Non-medicinal ingredients

Sorbitol 70%, Caramel, yerba mate, Huile d'orange, (p)-hydroxybenzoate de propyle, (p)-hydroxybenzoate de méthyle, Eau purifiée, Glycérine, oligofructose

PopulationAgeQuantity per servingFrequency
AdultesNot specified10 mL1 Tous les jours

Uses authorised in Canada

La Glucosamine 1000 mg de Pharmavigor aide à soulager la douleur liée à l'osteoarthrite.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80002033

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line